Tower Research Capital (TRC)’s enVVeno Medical NVNO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.36K | Sell |
592
-1,012
| -63% | -$4.04K | ﹤0.01% | 4661 |
|
|
2025
Q1 | $4.22K | Sell |
1,604
-5,144
| -76% | -$13.5K | ﹤0.01% | 4286 |
|
|
2024
Q4 | $20.4K | Buy |
6,748
+5,894
| +690% | +$17.8K | ﹤0.01% | 3169 |
|
|
2024
Q3 | $2.87K | Sell |
854
-1,534
| -64% | -$5.15K | ﹤0.01% | 4931 |
|
|
2024
Q2 | $12.5K | Sell |
2,388
-1,099
| -32% | -$5.77K | ﹤0.01% | 4024 |
|
|
2024
Q1 | $19K | Buy |
3,487
+640
| +22% | +$3.48K | ﹤0.01% | 3050 |
|
|
2023
Q4 | $14.6K | Buy |
2,847
+2,826
| +13,457% | +$14.5K | ﹤0.01% | 3869 |
|
|
2023
Q3 | $113 | Sell |
21
-3,202
| -99% | -$17.2K | ﹤0.01% | 5716 |
|
|
2023
Q2 | $9.93K | Buy |
3,223
+1,664
| +107% | +$5.13K | ﹤0.01% | 4172 |
|
|
2023
Q1 | $7K | Sell |
1,559
-299
| -16% | -$1.34K | ﹤0.01% | 4758 |
|
|
2022
Q4 | $9K | Sell |
1,858
-790
| -30% | -$3.83K | ﹤0.01% | 4226 |
|
|
2022
Q3 | $17K | Buy |
2,648
+2,107
| +389% | +$13.5K | ﹤0.01% | 4077 |
|
|
2022
Q2 | $2K | Buy |
541
+236
| +77% | +$872 | ﹤0.01% | 5575 |
|
|
2022
Q1 | $2K | Sell |
305
-481
| -61% | -$3.15K | ﹤0.01% | 5576 |
|
|
2021
Q4 | $5K | Buy |
+786
| New | +$5K | ﹤0.01% | 5174 |
|
|
2021
Q3 | – | Sell |
-184
| Closed | -$1K | – | 6042 |
|
|
2021
Q2 | $1K | Sell |
184
-406
| -69% | -$2.21K | ﹤0.01% | 5226 |
|
|
2021
Q1 | $4K | Buy |
590
+488
| +478% | +$3.31K | ﹤0.01% | 4800 |
|
|
2020
Q4 | $1K | Buy |
+102
| New | +$1K | ﹤0.01% | 5020 |
|
|
2018
Q4 | – | Sell |
-28
| Closed | -$2K | – | 4188 |
|
|
2018
Q3 | $2K | Buy |
+28
| New | +$2K | ﹤0.01% | 3456 |
|